Want to join the conversation?
$BMY 2Q15 Q&A: Anderson of Bernstein had a question about Opdivo pricing in Germany relative to US. Murdo explained that European thought leaders think that consistent with some perspectives with US thought leaders post ASCO, role of PD-1 is unclear in selecting patients. In Germany BMY has a public price of EUR7,421 roughly per month on July 15.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.